Company: CPSH
Filing Date: 2025-10-08
Form Type: 424B5
Source: 0001437749-25-030673
Chunk: 25

Company: CPS TECHNOLOGIES CORP/DE/
Filing Date: 2025-10-08
Form: 424B5
Chunk 25
---
</div>

This prospectus supplement and the accompanying prospectus incorporate important business and financial information about us that is not included in or delivered with this prospectus supplement and the accompanying prospectus. The information incorporated by reference is considered to be part of this prospectus supplement and the accompanying prospectus, except for any information superseded by information in this prospectus supplement and the accompanying prospectus. This prospectus supplement and the accompanying prospectus incorporate by reference the documents set forth below that have previously been filed with the SEC:

We are also incorporating by reference additional documents that we may file with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (excluding any information furnished pursuant to Item 2.02 or Item 7.01 on any current report on Form 8-K and any corresponding information furnished under Item 9.01 or included as an exhibit) after the date of this prospectus supplement and prior to the completion of this offering contemplated hereby, but excluding any information furnished to, rather than filed with, the SEC.

You may request a free copy of any of the documents incorporated by reference in this prospectus supplement by writing or telephoning us at the following address:

<div align='center'>111 South Worcester Street,

Norton, Massachusetts 02766

(508) 222-0614</div>

Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in those documents.

<div align='center'>S-18

PROSPECTUS

CPS TECHNOLOGIES CORP.

$25,000,000

Common Stock
Preferred Stock
Warrants
Rights
Units

We may offer and sell, from time to time in one or more offerings, up to $25,000,000 in the aggregate of common stock, preferred
stock, warrants, rights and units, in any combination. We intend to use the proceeds, if any, for general corporate purposes unless
otherwise indicated in the applicable prospectus supplement.</div>

This prospectus provides you with a general description of the securities offered. Each time we offer and sell securities, we will file a prospectus supplement to this prospectus that contains specific information about the offering and, if applicable, the amounts, prices and terms of the securities. Such supplements may also add, update or change information contained in this prospectus. You should carefully read this prospectus and the applicable prospectus supplement before you invest in any of our securities. This